Seminowicz D A, Mayberg H S, McIntosh A R, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S
Rotman Research Institute, Baycrest Centre for Geriatric Care, 3560 Bathurst Street, Toronto, Ontario, Canada M6A 2E1.
Neuroimage. 2004 May;22(1):409-18. doi: 10.1016/j.neuroimage.2004.01.015.
This paper reports the results of an across lab metanalysis of effective connectivity in major depression (MDD). Using FDG PET data and Structural Equation Modeling, a formal depression model was created to explicitly test current theories of limbic-cortical dysfunction in MDD and to characterize at the path level potential sources of baseline variability reported in this patient population. A 7-region model consisting of lateral prefrontal cortex (latF9), anterior thalamus (aTh), anterior cingulate (Cg24), subgenual cingulate (Cg25), orbital frontal cortex (OF11), hippocampus (Hc), and medial frontal cortex (mF10) was tested in scans of 119 depressed patients and 42 healthy control subjects acquired during three separate studies at two different institutions. A single model, based on previous theory and supported by anatomical connectivity literature, was stable for the three groups of depressed patients. Within the context of this model, path differences among groups as a function of treatment response characteristics were also identified. First, limbic-cortical connections (latF9-Cg25-OF11-Hc) differentiated drug treatment responders from nonresponders. Second, nonresponders showed additional abnormalities in limbic-subcortical pathways (aTh-Cg24-Cg25-OF11-Hc). Lastly, more limited limbic-cortical (Hc-latF9) and cortical-cortical (OF11-mF10) path differences differentiated responders to cognitive behavioral therapy (CBT) from responders to pharmacotherapy. We conclude that the creation of such models is a first step toward full characterization of the depression phenotype at the neural systems level, with implications for the future development of brain-based algorithms to determine optimal treatment selection for individual patients.
本文报告了一项针对重度抑郁症(MDD)有效连接性的跨实验室荟萃分析结果。利用氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)数据和结构方程模型,创建了一个正式的抑郁症模型,以明确检验当前关于MDD边缘-皮质功能障碍的理论,并在路径层面描述该患者群体中报告的基线变异性的潜在来源。在两个不同机构进行的三项独立研究中,对119名抑郁症患者和42名健康对照者进行扫描,测试了一个由外侧前额叶皮质(latF9)、前丘脑(aTh)、前扣带回(Cg24)、膝下扣带回(Cg25)、眶额皮质(OF11)、海马体(Hc)和内侧前额叶皮质(mF10)组成的7区域模型。基于先前理论并得到解剖学连接文献支持的单一模型,在三组抑郁症患者中是稳定的。在该模型的背景下,还确定了不同组之间作为治疗反应特征函数的路径差异。首先,边缘-皮质连接(latF9-Cg25-OF11-Hc)区分了药物治疗反应者和无反应者。其次,无反应者在边缘-皮质下通路(aTh-Cg24-Cg25-OF11-Hc)中表现出额外的异常。最后,更有限的边缘-皮质(Hc-latF9)和皮质-皮质(OF11-mF10)路径差异区分了认知行为疗法(CBT)反应者和药物疗法反应者。我们得出结论,创建这样的模型是在神经系统层面全面表征抑郁症表型的第一步,这对未来基于大脑的算法的发展具有启示意义,该算法可用于为个体患者确定最佳治疗选择。